Armstrong, A. J., Marcos, E. C., Oudard, S., Gao, X., Xing, N., Gupta, S., Ghaznawi, F., Burock, K., Galli, G. G., Azad, A. (2026). TulmiSTAR-01: A phase I/II dose optimization study of tulmimetostat in combination with luxdegalutamide versus standard of care (SOC) in patients (pts) with progressive metastatic castrate-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.tps301